Literature DB >> 22985192

Comparison between clinical, ultrasound, CT, MRI, and pathology findings in dogs presented for suspected thyroid carcinoma.

Olivier Taeymans1, Dominique G Penninck, Rachel M Peters.   

Abstract

This study compares clinical, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and pathology findings in 16 prospectively, and seven retrospectively recruited dogs presented for suspected thyroid carcinoma. Of these, 17 were confirmed thyroid carcinoma, while six were initially misdiagnosed. These included four carotid body tumors, one para-esophageal abscess, and one undifferentiated squamous cell carcinoma. Thyroid carcinomas occurred in older dogs without evidence of sex predilection, and were more often unilateral. All were large, heterogeneous, moderately to strongly vascularized, and most commonly contained areas of dystrophic mineralization and/or fluid accumulations. On MRI, thyroid carcinomas appeared hyperintense compared to surrounding musculature in all imaging sequences used, while on CT they had a lower attenuation value than normal thyroid gland tissue. Histologically confirmed tumor capsule disruption with invasion of the surrounding structures was most commonly detected with MRI. Palpation was not an accurate predictor of locally invasive vs. well-encapsulated masses. Computed tomography had the highest specificity (100%) and MRI had the highest sensitivity (93%) in diagnosing thyroid carcinoma, while ultrasound had considerably lower results. We conclude that ultrasound is adequate for use as a screening tool for dogs with suspected thyroid carcinoma, but recommend either CT or MRI for preoperative diagnosis and staging.
© 2012 Veterinary Radiology & Ultrasound.

Entities:  

Mesh:

Year:  2012        PMID: 22985192     DOI: 10.1111/j.1740-8261.2012.01966.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  9 in total

1.  MRI and ultrasonography detection of cervical lymph node metastases in differentiated thyroid carcinoma before reoperation.

Authors:  Zeming Liu; Xueqiong Xun; Yaozong Wang; Li Mei; Long He; Wen Zeng; Cong-Yi Wang; Huang Tao
Journal:  Am J Transl Res       Date:  2014-01-15       Impact factor: 4.060

2.  Hypofractionated radiation therapy of a thyroid tumor in a pet raccoon (Procyon lotor).

Authors:  Cassie Kroncke; Samuel E Hocker; Katherine Rainwater; David Ruslander; Eli B Cohen; Sara Gardhouse
Journal:  Can Vet J       Date:  2022-07       Impact factor: 1.075

3.  Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma.

Authors:  M Campos; R Ducatelle; G Rutteman; H S Kooistra; L Duchateau; H de Rooster; K Peremans; S Daminet
Journal:  J Vet Intern Med       Date:  2014-09-24       Impact factor: 3.333

Review 4.  Imaging in Non-neurologic Oncologic Treatment Planning of the Head and Neck.

Authors:  Katherine S Hansen; Michael S Kent
Journal:  Front Vet Sci       Date:  2019-03-28

5.  Bilateral thyroid adenomas in an alpaca.

Authors:  Kate Burbery; Olivier Simon; Lucy Woolford; Gustavo Ferlini Agne
Journal:  J Vet Intern Med       Date:  2021-10-09       Impact factor: 3.333

6.  Clinical features and treatment outcomes of 41 dogs with sublingual ectopic thyroid neoplasia.

Authors:  M R Broome; M E Peterson; J R Walker
Journal:  J Vet Intern Med       Date:  2014-07-23       Impact factor: 3.333

Review 7.  All lesions great and small, part 2. Diagnostic cytology in veterinary medicine.

Authors:  Leslie C Sharkey; Davis M Seelig; Jed Overmann
Journal:  Diagn Cytopathol       Date:  2014-02-19       Impact factor: 1.582

8.  CLINICAL AND MAGNETIC RESONANCE IMAGING FEATURES OF INFLAMMATORY VERSUS NEOPLASTIC MEDIAL RETROPHARYNGEAL LYMPH NODE MASS LESIONS IN DOGS AND CATS.

Authors:  Philippa J Johnson; Richard Elders; Pascaline Pey; Ruth Dennis
Journal:  Vet Radiol Ultrasound       Date:  2015-09-07       Impact factor: 1.363

9.  Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence.

Authors:  Rajiv Ramasawmy; S Peter Johnson; Thomas A Roberts; Daniel J Stuckey; Anna L David; R Barbara Pedley; Mark F Lythgoe; Bernard Siow; Simon Walker-Samuel
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.